The Company’s objective wasto progress the commercialisation of biodegradable hygiene products, including nappies and wipes. Following a review by an independent consultant commission by the board the previous year,theDirectors atthe time decided to substantially reduce the Australian sales operations and become a licensor of itsintellectual property in biodegradable hygiene technologies. During the yearthe Company signed a licence agreement with Containers and Packaging Corporation (CPC) in the Philippinesto licence the Company’s biodegradable hygiene technology to manufacture, market and sell products in the Asia Pacific region on a net profit royalty basis. CPC is currently undergoing manufacturing tests and determining which parts of the range it will lead with and in which markets. The Company has also been pursuing opportunities to acquire other intellectual property assets to broaden its asset base and which have the potential to deliver new revenue streams. In September 2012, the Company took an 11% stake in privately held US company, Cynata Incorporated, which is developing a therapeutic stem cell technology platform. In December 2012, thisstake wasincreased to 27% for a combined outlay ofUS$750,000.
ECQ Price at posting:
2.9¢ Sentiment: Buy Disclosure: Held